Belgian biotech developing radio-immunotherapeutic drugs for cancer.
Founders
Tony Lahoutte(Belgium · ♂)— As head of VUB's Molecular Imaging group and UZ Brussel's nuclear medicine department, he spun out Precirix to turn camelid antibody research into precision radiopharmaceuticals.
Matthias D'Huyvetter(Belgium · ♂)— A VUB researcher in radiolabelled single-domain antibodies, he co-founded Precirix to develop targeted radiotherapy against cancer.
Jens De Vos(Belgium · ♂)— Coming from VUB's molecular imaging research, he co-founded Precirix to commercialize camelid-antibody radiopharmaceuticals.
In the network
Shares the most investors with (number = shared investors):